Persistent Lupus Anticoagulant Positivity and Long-Term Sequelae Following Mild COVID-19.

Publication date: Oct 01, 2024

We report a case of persistent lupus anticoagulant (LAC) positivity following mild COVID-19 in a 64-year-old Japanese male with a history of atrial fibrillation. The patient experienced post-COVID-19 condition symptoms, including intermittent fatigue, taste disturbance, and persistent numbness in the upper arm, persistently for over 10 months. Laboratory investigations revealed prolonged activated partial thromboplastin time (aPTT) of 70. 0 seconds, positive LAC of 1. 5, and positive anti-cardiolipin-beta2-glycoprotein I complex antibody of 4. 3 U/mL. This case highlights the potential for long-term LAC positivity after mild COVID-19 and raises questions about its association with post-COVID-19 conditions. The persistence of LAC positivity is noteworthy, as previous studies suggest that virus-induced LAC typically resolves within two to three months. Further research is needed to elucidate the long-term dynamics of LAC in post-COVID-19 condition patients and its clinical implications, particularly in relation to thrombotic complications associated with COVID-19.

Concepts Keywords
Beta2 antiphospholipid antibody
Cardiolipin covid-19
Fatigue lupus anti-coagulant
Japanese post-covid-19 conditions (pcc)
Months

Semantics

Type Source Name
disease MESH Sequelae
disease MESH COVID-19
disease IDO history
disease MESH atrial fibrillation
disease MESH numbness
drug DRUGBANK Cardiolipin
drug DRUGBANK Factor IX Complex (Human)

Original Article

(Visited 2 times, 1 visits today)